Consolidated Statements of Operations (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Net sales	$ 3,244	$ 3,077	$ 6,270	$ 5,829
Cost of products sold	1,011	945	1,966	1,839
Gross profit	2,233	2,132	4,304	3,990
Operating expenses:
Selling, general and administrative expenses	1,165	1,121	2,225	2,139
Research and development expenses	335	298	654	574
Royalty expense	11	12	23	24
Amortization expense	204	180	402	365
Intangible asset impairment charges	7	45	7	45
Contingent consideration net expense (benefit)	36	(85)	48	(91)
Restructuring net charges (credits)	11	3	14	8
Litigation-related net charges (credits)	42	298	42	302
Gain on disposal of businesses and assets	0	(2)	0	(9)
Operating expenses	1,810	1,870	3,415	3,358
Operating income (loss)	423	262	889	632
Other income (expense):
Interest expense	(64)	(86)	(343)	(168)
Other, net	(14)	(26)	(46)	11
Income (loss) before income taxes	345	149	501	474
Income tax expense (benefit)	85	(37)	131	(53)
Net income (loss)	260	186	370	527
Preferred stock dividends	(14)	(14)	(28)	(28)
Net income (loss) available to common stockholders	$ 246	$ 172	$ 342	$ 500
Net income (loss) per common share — basic	$ 0.17	$ 0.12	$ 0.24	$ 0.35
Net income (loss) per common share — assuming dilution	$ 0.17	$ 0.12	$ 0.24	$ 0.35
Weighted-average shares outstanding
Basic	1,429.7	1,421.3	1,428.8	1,420.0
Assuming dilution	1,437.8	1,432.5	1,438.1	1,431.7